Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV Antiretroviral Drugs and Metabolism.

Next Previous
Trial Profile

HIV Antiretroviral Drugs and Metabolism.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ritonavir (Primary) ; Atazanavir; Efavirenz; Lopinavir/ritonavir
  • Indications HIV infections
  • Focus Pharmacodynamics

Most Recent Events

  • 30 Jun 2010 Results of ritonavir effects on insulin sensitivity have been published in the Journal of Acquired Immune Deficiency Syndromes.
  • 09 Oct 2009 Planned number of patients (60) added as reported by ClinicalTrials.gov.
  • 27 Dec 2007 Status changed from initiated to recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top